Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terameprocol (EM-1421) in Recurrent High Grade Glioma
NCT00404248Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Jan 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of terameprocol in high-grade glioma (HGG), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Jan 2007; status: completed.
02
Drugs
terameprocol
03
Conditions
high-grade glioma (HGG)
Beyond the preview
Go deeper on NCT00404248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00404248.